What else can I do but take drugs? The future of research in nonpharmacological treatment in early inflammatory arthritis

被引:0
|
作者
Li, LC
机构
[1] Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON K1Y 4E9, Canada
[2] Arthrit Soc, Ontario Div, Ottawa, ON, Canada
关键词
complementary therapies; outcome assessment; rheumatoid arthritis; clinical trials;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonpharmacological treatments. including physiotherapy and occupational therapy. have assumed a complementary role to drug therapy in managing inflammatory arthritis. Clinicians and researchers are facing 3 major challenges concerning the use of these treatments. First, strong evidence is only present in a few nonpharmacological interventions, such as exercise, patient education. and low level laser in the treatment of rheumatoid arthritis. The evidence on the majority of interventions is. however. weak or inconclusive. Second, knowledge is lacking on the elements associated with models of non pharmacological care. The multidisciplinary team approach has been viewed as the standard for arthritis treatment: however. the team structure and the communication style among team members vary around the world. The influence of these elements on treatment success remains unclear. Finally, disparities in knowledge management and translation in nonpharmacological research have hindered the clinical use of these treatments and the growth of research in the field. To address the challenges, the author is recommending 4 research priorities for nonpharmacological treatments: 1. Evaluation of less well-studied interventions: 2. Understanding the relationships among rehabilitation-related variables and disability; 3. Development and evaluation of innovative care models: and 4. Design and evaluation of knowledge transfer innovations.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 50 条
  • [1] What Else Can I Do?
    Seungjae, Han
    [J]. SPACE, 2023, (668): : 82 - 87
  • [2] It's Cool but What Else can I Do?
    Read, Janet C.
    [J]. PROCEEDINGS OF 4TH INTERNATIONAL CONFERENCE ON HCI AND UX (CHIUXID 2018), 2018, : 105 - 108
  • [3] What Can I Do to Help My Patient When I Think There Is Nothing Else I Can Do?
    Morse, Alan R.
    [J]. OPHTHALMOLOGY, 2018, 125 (07) : 959 - 961
  • [4] I Can't Stand CPAP. What Else Can You Do For Me?
    Berry, Richard B.
    Smith, Charles L., Jr.
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2005, 1 (01): : 91 - 93
  • [5] OBESITY The future of obesity treatment: what can drugs and surgery offer?
    Watts, Geoff
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [6] "WHAT ELSE CAN I DO?": EXAMINING INTERNALIZED HOMOPHOBIA AND COGNITIVE INFLEXIBILITY IN THE CONTEXT OF MINORITY STRESS
    Deng, Wisteria
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S411 - S411
  • [7] "Doctor, what else can I do for my glaucoma?"Exercise, nicotinamide and other lifestyle interventions
    Crowston, Jonathan G.
    Chrysostomou, Vicki
    Bell, Katharina C.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (04): : 289 - 290
  • [8] Doctor is there anything else that I can do for my glaucoma?: Alternative therapy for glaucoma, what is the evidence?
    Megevand, G. Sunaric
    [J]. ACTA OPHTHALMOLOGICA, 2017, 95
  • [9] Criticisms of drugs in early development for the treatment of depression: what can be improved?
    Wang, Sheng-Min
    Han, Changsu
    Pae, Chi-Un
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (04) : 445 - 453
  • [10] "What else can we do?"-Provider perspectives on treatment-resistant depression in late life
    Hamm, Megan E.
    Karp, Jordan F.
    Lenard, Emily
    Dawdani, Alicia
    Lavretsky, Helen
    Lenze, Eric J.
    Mulsant, Benoit H.
    Reynolds, Charles F.
    Roose, Steven P.
    Brown, Patrick J.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (04) : 1190 - 1197